• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Improving health evaluations to capture wider value of therapeutics and incentivise innovation.

作者信息

Chan Mei Sum, Kowalik Jack C, Ashfield Tom, Pearson-Stuttard Jonathan

机构信息

Health Analytics, Lane Clark & Peacock LLP, London, United Kingdom.

UK Health & Value, Pfizer Ltd., Tadworth, United Kingdom.

出版信息

Front Public Health. 2023 Mar 31;11:1119652. doi: 10.3389/fpubh.2023.1119652. eCollection 2023.

DOI:10.3389/fpubh.2023.1119652
PMID:37064703
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10102525/
Abstract
摘要

相似文献

1
Improving health evaluations to capture wider value of therapeutics and incentivise innovation.改进健康评估，以捕捉治疗手段更广泛的价值并激励创新。
Front Public Health. 2023 Mar 31;11:1119652. doi: 10.3389/fpubh.2023.1119652. eCollection 2023.
2
Innovation sustainability in challenging health-care contexts: embedding clinically led change in routine practice.在具有挑战性的医疗环境中实现创新的可持续性：将临床主导的变革融入常规实践。
Health Serv Manage Res. 2012 Nov;25(4):190-9. doi: 10.1177/0951484812474246.
3
Innovation in Home Care: Time for a New Payment Model.居家护理的创新：是时候采用新的支付模式了。
JAMA. 2020 Jun 23;323(24):2474-2475. doi: 10.1001/jama.2020.1036.
4
Exploring Innovation Capabilities of Hospital CIOs: An Empirical Assessment.探索医院首席信息官的创新能力：一项实证评估
Stud Health Technol Inform. 2017;235:383-387.
5
Innovation Centers in Health Care Delivery Systems: Structures for Success.医疗服务提供系统中的创新中心：成功的结构。
J Med Internet Res. 2022 Feb 10;24(2):e33961. doi: 10.2196/33961.
6
Emerging lessons from regional and state innovation in value-based payment reform: balancing collaboration and disruptive innovation.基于价值的支付改革中区域和州创新的新经验教训：平衡协作与颠覆性创新。
Milbank Q. 2014 Sep;92(3):568-623. doi: 10.1111/1468-0009.12078.
7
A Policy Framework for Health Systems to Promote Triple Aim Innovation.促进三重目标创新的卫生系统政策框架。
Healthc Pap. 2016;15(3):9-23.
8
Continuous innovation in health care: implications of the Geisinger experience.医疗保健的持续创新：基于 Geisinger 经验的启示。
Health Aff (Millwood). 2008 Sep-Oct;27(5):1235-45. doi: 10.1377/hlthaff.27.5.1235.
9
Improvement of hospital performance through innovation: toward the value of hospital care.通过创新提升医院绩效：迈向医院护理的价值
Health Care Manag (Frederick). 2013 Apr-Jun;32(2):129-40. doi: 10.1097/HCM.0b013e31828ef60a.
10
Improvement of hospital performance through innovation: toward the value of hospital care.通过创新提升医院绩效：迈向医院护理的价值
Health Care Manag (Frederick). 2013 Jul-Sep;32(3):268-79.

引用本文的文献

1
Real-world cost-effectiveness of nirmatrelvir-ritonavir as treatment for SARS-CoV-2 infection in the Belgian setting with omicron variant.在比利时奥密克戎变异株背景下，奈玛特韦-利托那韦作为治疗新冠病毒感染的真实世界成本效益分析
Front Public Health. 2025 Feb 3;12:1432821. doi: 10.3389/fpubh.2024.1432821. eCollection 2024.
2
Health technology assessment and innovation: here to help or hinder?卫生技术评估与创新：是帮手还是阻碍？
Int J Technol Assess Health Care. 2024 Oct 24;40(1):e37. doi: 10.1017/S026646232400059X.

本文引用的文献

1
Assessing Definitions and Incentives Adopted for Innovation for Pharmaceutical Products in Five High-Income Countries: A Systematic Literature Review.评估五个高收入国家采用的药品创新定义和激励措施：系统文献回顾。
Pharmaceut Med. 2023 Jan;37(1):53-70. doi: 10.1007/s40290-022-00457-5. Epub 2023 Jan 17.
2
Can the UK 'Netflix' Payment Model Boost the Antibacterial Pipeline?英国“网飞”式付费模式能否提振抗菌药物研发管线？
Appl Health Econ Health Policy. 2023 May;21(3):365-372. doi: 10.1007/s40258-022-00786-1. Epub 2023 Jan 17.
3
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担：系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
4
Comparing the Fiscal Consequences of Controlled and Uncontrolled Osteoarthritis Pain Applying a UK Public Economic Perspective.从英国公共经济视角比较控制和未控制的骨关节炎疼痛的财政后果。
J Health Econ Outcomes Res. 2021 Jun 28;8(1):127-136. doi: 10.36469/001c.24629. eCollection 2021.
5
Realising the broader value of vaccines in the UK.认识到疫苗在英国更广泛的价值。
Vaccine X. 2021 Apr 6;8:100096. doi: 10.1016/j.jvacx.2021.100096. eCollection 2021 Aug.
6
Guidance for Demonstrating the Societal Value of new Antibiotics.新型抗生素社会价值论证指南。
Front Pharmacol. 2021 Feb 1;11:618238. doi: 10.3389/fphar.2020.618238. eCollection 2020.
7
NICE's approach to measuring value.英国国家卫生与临床优化研究所衡量价值的方法。
BMJ. 2021 Jan 5;372:n7. doi: 10.1136/bmj.n7.
8
Cost-Effectiveness of Antiviral Treatments for Pandemics and Outbreaks of Respiratory Illnesses, Including COVID-19: A Systematic Review of Published Economic Evaluations.抗病毒治疗在大流行和呼吸道疾病（包括 COVID-19）暴发中的成本效益：已发表经济评估的系统综述。
Value Health. 2020 Nov;23(11):1409-1422. doi: 10.1016/j.jval.2020.07.002. Epub 2020 Sep 6.
9
A new Health Index for England: the Chief Medical Officer's 2018 annual report.英国新的健康指数：首席医疗官2018年度报告。
Lancet. 2019 Jan 5;393(10166):10-11. doi: 10.1016/S0140-6736(18)33210-0. Epub 2018 Dec 21.
10
Pandemic risk: how large are the expected losses?大流行风险：预期损失有多大？
Bull World Health Organ. 2018 Feb 1;96(2):129-134. doi: 10.2471/BLT.17.199588. Epub 2017 Dec 5.